Learn More
TARGETMOL CHEMICALS INC ENCORAFENIB 10MG

Supplier: TARGETMOL CHEMICALS INC T6487

Also available in 1 mg 5 mg 25 mg 50 mg and bulk. Please contact Fisher for quotes. Encorafenib (LGX818) is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity. purity: 99%
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.